The synthesis, purification and characterisation of two coordination isomers of ruthenium() and osmium () complexes containing the ligand 3-(pyrazin-2Ј-yl)-5-(pyridin-2Љ-yl)-1,2,4-triazole (Hppt) are described. The X-ray and molecular structure of the complex [Ru(bipy) 2 (ppt)]PF 6 ؒCH 3 OH (1a) is reported, where the Ru(bipy) 2 -centre is bound to the ppt Ϫ ligand via the pyridine nitrogen and the N1 atom of the triazole ring. 1 H NMR spectroscopic measurements confirm that in the second isomer (1b) the Ru(bipy) 2 -moiety is bound via the N2 atom of the triazole ring and the pyrazine ring. Partially deuteriated metal complexes are utilised to facilitate interpretation of 1 H NMR spectra. The redox and electronic properties indicate that there are significant differences in the electronic properties of the two coordination isomers obtained. The acid-base properties of the compounds are also reported and show that the pK a of the 1,2,4-triazole ring varies systematically depending on the nature of the non-coordinating substituent. Analysis of these data indicates a significant electronic interaction between the pyridyl/pyrazyl rings and the 1,2,4-triazole ring in the coordinated ppt Ϫ ligand.
Diphenylphosphinodithioic acid (6b) and its triethyl ammonium salt (6a) were prepared by two new synthetic pathways, each employing cheap and readily available starting materials. These facile one-pot reactions were conducted on a kilogram scale and produced the desired products in high yield and quality, thereby surpassing all previously known routes. The synthesis of triethyl ammonium salts of 6H-dibenzo[c,e][1,2]oxaphosphinine-6-thiolate 6-sulfide (3a) was also further improved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.